Insmed (INSM) Announces FDA Acceptance for Filing of NDA for ALIS in NTM Lung Disease Caused by MAC

May 16, 2018 8:06 AM

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, announced today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found